BB-031

DRUG2 trials

Sponsors

Basking Biosciences, Inc.

Conditions

Acute Ischemic StrokeHealthy VolunteersPharmacodynamicsPharmacokinetics

Phase 1

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

CompletedNCT07202663

Basking Biosciences, Inc.Healthy Volunteers, Pharmacodynamics, Pharmacokinetics

Start: 2025-11-05End: 2026-03-18Updated: 2026-04-06

Phase 2

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

RecruitingNCT06226805

Basking Biosciences, Inc.Acute Ischemic Stroke

Start: 2024-07-31End: 2027-09-01Target: 228Updated: 2026-05-14